• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Labcorp and Legacy Health Finalize Comprehensive Laboratory Relationship

Share:

November 27, 2023

LabCorp (NYSE: LH), a leading global provider of innovative laboratory services, has finalized the acquisition of select assets of Legacy Health’s outreach laboratory business, alongside managing Legacy’s inpatient hospital laboratories through a long-term agreement. This strategic move aims to enhance access to LabCorp’s advanced diagnostic testing in Oregon and Southwest Washington. Rajat Mehta, Labcorp’s Senior Vice President, highlights the expansion’s significance for communities. Legacy Health, a six-hospital system serving Portland, Southwest Washington, and Oregon’s mid-Willamette Valley, maintains ownership of its hospital labs. The collaboration aims to offer enhanced healthcare services by integrating LabCorp’s diagnostic capabilities for improved patient care.

LabCorp (NYSE: LH), a global leader in innovative and comprehensive laboratory services, announced today the completion of the previously announced transaction with Legacy Health to acquire select assets of Legacy’s outreach laboratory business. Labcorp also now manages Legacy’s inpatient hospital laboratories through a long-term agreement to provide staffing, leadership, scientific knowledge, analytics, supply chain services, and laboratory support.

“This milestone will benefit communities in Oregon and Southwest Washington by expanding access to Labcorp’s industry-leading laboratory services and diagnostic testing,” said Rajat Mehta, Senior Vice President of Labcorp’s West Division. “The closing of this deal reinforces Labcorp’s commitment to providing access to high-quality testing throughout the region by building on Legacy Health’s longstanding history of serving communities.”

Legacy is a six-hospital health system with a full-service children’s hospital, a 24-hour behavioral health center, and more than 80 primary care, specialty, and urgent care clinics. Legacy provides comprehensive healthcare services across its communities in Portland, Southwest Washington, and Oregon’s mid-Willamette Valley.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Upon completion of full integration, healthcare providers and patients throughout the region will have more direct and convenient access to Labcorp’s full range of laboratory services. Legacy continues to maintain ownership and licensure of its hospital laboratories.

“The providers and patients Legacy serves will benefit from Labcorp’s innovative diagnostic capabilities and comprehensive laboratory services,” said Kecia Kelly, Senior Vice President and Chief Nursing Officer. “Partnering with Labcorp furthers our mission of good health for all.”

Source: Biospace

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Supriya Lifescience Targets Rs 1,600 Crore RevenueSupriya Lifescience Targets Rs 1,600 Crore Revenue
  • Ayala Pharmaceuticals Announces Closing of Merger with BiosightAyala Pharmaceuticals Announces Closing of Merger with Biosight
  • Arsenal Capital Partners Acquires AccumenArsenal Capital Partners Acquires Accumen
  • How Physicians Can Help Guide Patients Through Clinical TrialsHow Physicians Can Help Guide Patients Through Clinical Trials
  • Breathtec to Open New Drug Development Division, Signs LOI to acquire 100% of Clinical Stage Nash Pharmaceuticals Inc.Breathtec to Open New Drug Development Division, Signs LOI to acquire 100% of Clinical Stage Nash Pharmaceuticals Inc.
  • Intel, Samsung Partner on Ai-based Ultrasound Solution for Anesthesia AdministrationIntel, Samsung Partner on Ai-based Ultrasound Solution for Anesthesia Administration
  • Bristol Myers Squibb Acquires RayzeBio | Radiopharmaceutical ExpansionBristol Myers Squibb Acquires RayzeBio | Radiopharmaceutical Expansion
  • Could blockchain ensure integrity of clinical trial data?Could blockchain ensure integrity of clinical trial data?

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications